TrialDepression and anxiety2015

A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder.

Carl Gommoll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.